Biotechnology in India. II
The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD 1 billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining...
Na minha lista:
| Auteurs principaux: | , , , |
|---|---|
| Outros Autores: | |
| Formato: | Livre numérique |
| Idioma: | Anglais |
| Publicado em: |
Berlin [etc.] :
Springer
2003.
Cham : Springer Nature |
| Colecção: | Advances in biochemical engineering, biotechnology
85 |
| Assuntos: | |
| Acesso em linha: | Accès sur la plateforme de l'éditeur Accès sur la plateforme Istex Accès Université d'Orléans Accès INSA CVL |
| Nota: |
Archives Springer e-books (Licence nationale) Archives Springer e-books (Licence nationale) |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Biotechnology in India, volume editors, T.K. Ghose, P. Ghosh, Berlin, Springer, 2003, 2 vol. (XI-292, XI-304 p.), Advances in biochemical engineering/biotechnology, 3-540-00609-5 • Biotechnology in India II, Texte imprimé, 9783662145890 • Biotechnology in India II, Texte imprimé, 9783662145906 |
| LEADER | 04403nam a22004457a 4500 | ||
|---|---|---|---|
| 001 | 948903 | ||
| 008 | 110927t20032003xxe ||| |||| 00| 0 eng d | ||
| 009 | PPN155197436 | ||
| 020 | |a 9783540364665 | ||
| 041 | 0 | |a eng | |
| 082 | |a 615 | ||
| 100 | 1 | |a Ghose, Tarun K., |d 19..- | |
| 245 | 1 | 0 | |a Biotechnology in India. |n II |c edited by Tarun K. Ghose, Purnendu Ghosh ; with contributions by S. Chand, S. K. Gupta, B. B. Lohray,...[et al.]. |
| 260 | |a Berlin [etc.] : |b Springer. | ||
| 260 | |a Cham : |b Springer Nature, |c 2003. | ||
| 490 | 0 | |a Advances in biochemical engineering, biotechnology |v 85 |x 1616-8542 | |
| 500 | |a Archives Springer e-books (Licence nationale) | ||
| 500 | |a Archives Springer e-books (Licence nationale) | ||
| 505 | 0 | |a Bioethanol in India: Recent Past and Emerging Future -- Commercialization of a Novel Fermentation Concept -- Bioprocessing of Therapeutic Proteins from the Inclusion Bodies of Escherichia coli -- Research and Application of Microbial Enzymes India s Contribution -- Molecular Mechanisms of Energy Transduction in Cells: Engineering Applications and Biological Implications -- Status of Immunodiagnosis and Immunocontraceptive Vaccines in India -- Medical Biotechnology in India. | |
| 506 | |a Accès en ligne pour les établissements français bénéficiaires des licences nationales | ||
| 506 | |a Accès soumis à abonnement pour tout autre établissement | ||
| 506 | |a Conditions particulières de réutilisation pour les bénéficiaires des licences nationales. https://www.licencesnationales.fr/springer-nature-ebooks-contrat-licence-ln-2017 | ||
| 520 | |a The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD 1 billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Ltd, Dr. | ||
| 650 | |a Génie chimique | ||
| 650 | |a Microbiologie | ||
| 650 | |a Chimie | ||
| 650 | |a Biotechnologie | ||
| 650 | |a Chimie industrielle | ||
| 700 | 1 | |a Ghosh, Purnendu, |d 1947- |4 pbd | |
| 700 | 1 | |a Chand, Subhash, |d 19..- |4 aut | |
| 700 | 1 | |a Gupta, Sushil Kumar, |d 1946- |4 aut | |
| 700 | 1 | |a Lohray, Braj B., |d 19..- |4 aut | |
| 776 | 0 | |0 077902297 |t Biotechnology in India |f volume editors, T.K. Ghose, P. Ghosh |c Berlin |n Springer |d 2003 |p 2 vol. (XI-292, XI-304 p.) |s Advances in biochemical engineering/biotechnology |z 3-540-00609-5 | |
| 776 | 0 | |t Biotechnology in India II |b Texte imprimé |z 9783662145890 | |
| 776 | 0 | |t Biotechnology in India II |b Texte imprimé |z 9783662145906 | |
| 856 | 4 | |q PDF |u https://doi.org/10.1007/3-540-36466-8 |z Accès sur la plateforme de l'éditeur | |
| 856 | 4 | |u https://revue-sommaire.istex.fr/ark:/67375/8Q1-V8T1LS2D-5 |z Accès sur la plateforme Istex | |
| 856 | 4 | |5 452349901:748054367 |u https://ezproxy.univ-orleans.fr/login?url=https://doi.org/10.1007/3-540-36466-8 |z Accès Université d'Orléans | |
| 856 | 4 | |5 180339901:751505609 |u https://ezproxy.insa-cvl.fr/login?qurl=https://doi.org/10.1007/3-540-36466-8 |z Accès INSA CVL | |
| 997 | |0 948903 |1 Livre numérique |a Ressource numérique |b INSA |b ENSA |c 0/Bibliothèque numérique/ |c 1/Bibliothèque numérique/Autre ressource numérique/ | ||